For U.S. Healthcare Professionals Only

Visit Sanofi U.S.:

The Sanofi Genzyme Rare Diseases Medical Affairs team helps Healthcare Professionals (HCPs) make evidence-based decisions that optimize health outcomes for patients through the generation, dissemination, and interpretation of accurate clinical and scientific information about:

  • Pompe disease
  • Gaucher disease
  • Fabry disease
  • MPS I
  • Acid sphingomyelinase deficiency (ASMD)

This website facilitates educational opportunities for HCPs through (1) web-based learning, and (2) informing of Scientific Education Programs conducted in collaboration with the Rare Diseases Medical Science Liaison (MSL) team.

The Rare Diseases MSL team supports Sanofi Genzyme’s pipeline and commercial products by delivering scientific information and education to HCPs, researchers, and payers with the ultimate goal of improved patient care.


Last Updated: Jun 22, 2021
What's New

What's New

New to molecular testing?
This 4 minute video illustrates the path a healthcare provider takes when ordering diagnostic testing for a lysosomal storage disease for the first time, and offers tips along the way.



Contact the Rare Diseases Medical Affairs team

Event Calendar

Event Calendar

Find Upcoming Events and Presentations on Our Event Calendar